|
|
||||||||
From the Neuroimmunology Laboratory, Departments of Immunology, Neurology, and Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Address correspondence and reprint request to Dr. Claudia F. Lucchinetti, Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.
Type 1 antineuronal nuclear autoantibody (ANNA-1, also known as "anti-Hu") is a marker of neurologic autoimmunity that is highly associated with small-cell lung carcinoma (SCLC). To determine the spectrum of symptoms and signs as well as the frequency of cancer in adult patients who are seropositive for ANNA-1, we reviewed 162 sequential patients (67% female) identified as ANNA-1-positive in a comprehensive immunofluorescence screening test. In 21% of these patients, the antibody test requested by the physician was not ANNA-1. By the end of the follow-up period, cancer had been found in 142 patients (88%). Ten of these lacked evidence of SCLC (4 had prostate carcinoma, 3 breast carcinoma, 1 both prostate carcinoma and melanoma, 1 lymphoma, and 1 squamous-cell lung carcinoma). Of the 132 patients(81%) with proven SCLC, 17 had one or more coexisting malignant neoplasms (6 had renal carcinoma, 4 another lung primary carcinoma, 3 prostate carcinoma, 3 breast carcinoma, and 4 assorted neoplasms). The diagnosis of SCLC in 128 patients(97%) followed the onset of paraneoplastic symptoms. SCLC was identified in 10 patients by chest MRI after an equivocal chest radiograph or CT; in 28 by bronchoscopy, mediastinoscopy, or thoracotomy; and in 7 at autopsy. Neurologic signs in decreasing frequency were neuropathy (sensory> mixed somatic > autonomic > cranial [especially cranial nerve VIII] > motor), cerebellar ataxia, limbic encephalitis, polyradiculopathy, associated Lambert-Eaton myasthenic syndrome, myopathy, myelopathy, opsoclonus/myoclonus, motor neuronopathy, brachial plexopathy, and aphasia. Nineteen patients had a solely gastrointestinal initial presentation, including gastroparesis, pseudo-obstruction, esophageal achalasia, or other dysmotility. We conclude that seropositivity for ANNA-1 can expedite the diagnosis and treatment of otherwise occult cancer in patients, especially tobacco abusers, with varied neurologic and gastroenterologic presentations. The search for SCLC should not end on discovering a different neoplasm.
Supported by grant CA-37343 from the National Cancer Institute.
Received November 15, 1996. Accepted in final form June 19, 1997.
This article has been cited by other articles:
![]() |
J Honnorat, S Cartalat-Carel, D Ricard, J P. Camdessanche, A F Carpentier, V Rogemond, F Chapuis, M Aguera, E Decullier, A M Duchemin, et al. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies J. Neurol. Neurosurg. Psychiatry, April 1, 2009; 80(4): 412 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Saiz, J Bruna, P Stourac, M C Vigliani, B Giometto, W Grisold, J Honnorat, D Psimaras, R Voltz, and F Graus Anti-Hu-associated brainstem encephalitis J. Neurol. Neurosurg. Psychiatry, April 1, 2009; 80(4): 404 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vincent, C. Buckley, B. Lang, S. Irani, S. J. Pittock, and K. Meng Tan CLINICAL SPECTRUM OF VOLTAGE-GATED POTASSIUM CHANNEL AUTOIMMUNITY Neurology, January 6, 2009; 72(1): 99 - 100. [Full Text] [PDF] |
||||
![]() |
K. R. Daffner, J. C. Sherman, R. G. Gonzalez, and R. P. Hasserjian Case 35-2008 -- A 65-Year-Old Man with Confusion and Memory Loss N. Engl. J. Med., November 13, 2008; 359(20): 2155 - 2164. [Full Text] [PDF] |
||||
![]() |
K. M. Tan, V. A. Lennon, C. J. Klein, B. F. Boeve, and S. J. Pittock Clinical spectrum of voltage-gated potassium channel autoimmunity Neurology, May 13, 2008; 70(20): 1883 - 1890. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Schulz, B. Randalls, and C. Counsell Anti-Hu syndrome: a rare presentation and a very difficult decision Practical Neurology, October 1, 2007; 7(5): 336 - 341. [Full Text] [PDF] |
||||
![]() |
J. W. de Beukelaar and P. A. S. Smitt Managing paraneoplastic neurological disorders. Oncologist, March 1, 2006; 11(3): 292 - 305. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Sutton, S. P. Harrell, and J. M. Wo Diagnosis and Management of Adult Patients With Chronic Intestinal Pseudoobstruction Nutr Clin Pract, February 1, 2006; 21(1): 16 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Martinu and A. S. Clay A 50-Year-Old Woman With Bilateral Vocal Cord Paralysis and Hilar Mass Chest, August 1, 2005; 128(2): 1028 - 1031. [Full Text] [PDF] |
||||
![]() |
A. I. Vinik, D. Anandacoomaraswamy, and J. Ullal Antibodies to Neuronal Structures: Innocent bystanders or neurotoxins? Diabetes Care, August 1, 2005; 28(8): 2067 - 2072. [Full Text] [PDF] |
||||
![]() |
N. G. Muller, K. Prass, and R. Zschenderlein Anti-Hu antibodies, sensory neuropathy, and Holmes-Adie syndrome in a patient with seminoma Neurology, January 11, 2005; 64(1): 164 - 165. [Full Text] [PDF] |
||||
![]() |
A. Llado, P. Mannucci, A. F. Carpentier, S. Paris, Y. Blanco, A. Saiz, J. Y. Delattre, and F. Graus Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes Neurology, November 23, 2004; 63(10): 1947 - 1949. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sinnreich, C. J. Klein, J. R. Daube, J. Engelstad, R. J. Spinner, and P. J.B. Dyck Chronic immune sensory polyradiculopathy: A possibly treatable sensory ataxia Neurology, November 9, 2004; 63(9): 1662 - 1669. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vernino and V. A. Lennon Autoantibody Profiles and Neurological Correlations of Thymoma Clin. Cancer Res., November 1, 2004; 10(21): 7270 - 7275. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Younes-Mhenni, M. F. Janier, L. Cinotti, J. C. Antoine, F. Tronc, V. Cottin, P. J. Ternamian, P. Trouillas, and J. Honnorat FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes Brain, October 1, 2004; 127(10): 2331 - 2338. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Linke, M. Schroeder, T. Helmberger, and R. Voltz Antibody-positive paraneoplastic neurologic syndromes: Value of CT and PET for tumor diagnosis Neurology, July 27, 2004; 63(2): 282 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Lawn, B. F. Westmoreland, M. J. Kiely, V. A. Lennon, and S. Vernino Clinical, Magnetic Resonance Imaging, and Electroencephalographic Findings in Paraneoplastic Limbic Encephalitis Mayo Clin. Proc., November 1, 2003; 78(11): 1363 - 1368. [Abstract] [PDF] |
||||
![]() |
S. Vernino, E. R. Eggenberger, L. R. Rogers, and V. A. Lennon Paraneoplastic neurological autoimmunity associated with ANNA-1 autoantibody and thymoma Neurology, September 24, 2002; 59(6): 929 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Buetow and E. Eggenberger ANNA-1--Induced Encephalitis Associated with Noninvasive Thymoma Am. J. Roentgenol., September 1, 2002; 179(3): 802 - 803. [Full Text] [PDF] |
||||
![]() |
P N Shams, A Waldman, and G T Plant B Cell lymphoma of the brain stem masquerading as myasthenia J. Neurol. Neurosurg. Psychiatry, February 1, 2002; 72(2): 271 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Camdessanche, J.-C. Antoine, J. Honnorat, C. Vial, P. Petiot, P. Convers, and D. Michel Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies: A clinical and electrophysiological study of 20 patients Brain, January 1, 2002; 125(1): 166 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Amato and M. P. Anderson Case 38-2001- A 51-Year-Old Woman with Lung Cancer and Neuropsychiatric Abnormalities N. Engl. J. Med., December 13, 2001; 345(24): 1758 - 1765. [Full Text] [PDF] |
||||
![]() |
J. H. Rees, S. F. Hain, M. R. Johnson, R. A. C. Hughes, D. C. Costa, P. J. Ell, G. Keir, and P. Rudge The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders Brain, November 1, 2001; 124(11): 2223 - 2231. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Brichory, D. Beer, F. LeNaour, T. Giordano, and S. Hanash Proteomics-based Identification of Protein Gene Product 9.5 as a Tumor Antigen That Induces a Humoral Immune Response in Lung Cancer Cancer Res., November 1, 2001; 61(21): 7908 - 7912. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Graus, F. Keime-Guibert, R. Rene, B. Benyahia, T. Ribalta, C. Ascaso, G. Escaramis, and J. Y. Delattre Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients Brain, June 1, 2001; 124(6): 1138 - 1148. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Abu-Shakra, D Buskila, M Ehrenfeld, K Conrad, and Y Shoenfeld Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies Ann Rheum Dis, May 1, 2001; 60(5): 433 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Barnett, J Prosser, I Sutton, G M Halmagyi, L Davies, C Harper, and J Dalmau Paraneoplastic brain stem encephalitis in a woman with anti-Ma2 antibody J. Neurol. Neurosurg. Psychiatry, February 1, 2001; 70(2): 222 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vernino, P. A. Low, R. D. Fealey, J. D. Stewart, G. Farrugia, and V. A. Lennon Autoantibodies to Ganglionic Acetylcholine Receptors in Autoimmune Autonomic Neuropathies N. Engl. J. Med., September 21, 2000; 343(12): 847 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Gultekin, M. R. Rosenfeld, R. Voltz, J. Eichen, J. B. Posner, and J. Dalmau Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients Brain, July 1, 2000; 123(7): 1481 - 1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. King RNA-binding analyses of HuC and HuD with the VEGF and c-myc 3'-untranslated regions using a novel ELISA-based assay Nucleic Acids Res., April 1, 2000; 28(7): e20 - e20. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Keime-Guibert, F. Graus, P. Broet, R. Rene, J. L. Molinuevo, C. Ascaso, and J. Y. Delattre Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor Neurology, November 1, 1999; 53(8): 1719 - 1719. [Abstract] [Full Text] |
||||
![]() |
J.-C. Antoine, J.-F. Mosnier, L. Absi, P. Convers, J. Honnorat, and D. Michel Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies J. Neurol. Neurosurg. Psychiatry, July 1, 1999; 67(1): 7 - 14. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |